Abbott Laboratories (ABT) : Everett Harris Co Ca scooped up 57,946 additional shares in Abbott Laboratories during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 26, 2016. The investment management firm now holds a total of 1,537,169 shares of Abbott Laboratories which is valued at $59,795,874.Abbott Laboratories makes up approximately 2.15% of Everett Harris Co Ca’s portfolio.
Abbott Laboratories closed down -0.05 points or -0.13% at $38.85 with 2,12,92,314 shares getting traded on Monday. Post opening the session at $38.85, the shares hit an intraday low of $38.42 and an intraday high of $39.12 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
Other Hedge Funds, Including , Sumitomo Life Insurance Co reduced its stake in ABT by selling 2,413 shares or 2.36% in the most recent quarter. The Hedge Fund company now holds 99,646 shares of ABT which is valued at $3,876,229. Abbott Laboratories makes up approx 0.50% of Sumitomo Life Insurance Co’s portfolio.Centurylink Investment Management Co reduced its stake in ABT by selling 1,415 shares or 3.62% in the most recent quarter. The Hedge Fund company now holds 37,657 shares of ABT which is valued at $1,659,921. Abbott Laboratories makes up approx 0.59% of Centurylink Investment Management Co’s portfolio.Community Bank N.a. reduced its stake in ABT by selling 700 shares or 1.64% in the most recent quarter. The Hedge Fund company now holds 41,890 shares of ABT which is valued at $1,846,511. Abbott Laboratories makes up approx 0.44% of Community Bank N.a.’s portfolio.Butensky Cohen Financial Security Inc boosted its stake in ABT in the latest quarter, The investment management firm added 1,265 additional shares and now holds a total of 32,187 shares of Abbott Laboratories which is valued at $1,418,803. Abbott Laboratories makes up approx 1.34% of Butensky Cohen Financial Security Inc’s portfolio.First Citizens Bank Trust Co reduced its stake in ABT by selling 2 shares or 0.03% in the most recent quarter. The Hedge Fund company now holds 7,974 shares of ABT which is valued at $351,494. Abbott Laboratories makes up approx 0.03% of First Citizens Bank Trust Co’s portfolio.
On the company’s financial health, Abbott Laboratories reported $0.41 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $0.39. The company had revenue of $4885.00 million for the quarter, compared to analysts expectations of $4777.68 million. The company’s revenue was down -.2 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.47 EPS.
Many Wall Street Analysts have commented on Abbott Laboratories. Company shares were Reiterated by RBC Capital Mkts on Apr 11, 2016 to “Outperform”, Firm has raised the Price Target to $ 48 from a previous price target of $45 .Shares were Reiterated by RBC Capital Mkts on Jan 29, 2016 to “Outperform” and Lowered the Price Target to $ 45 from a previous price target of $51 .
Abbott Laboratories (Abbott) is engaged in the discovery development manufacture and sale of a range of health care products. Abbott operates in four business segments: Established Pharmaceutical Products Diagnostic Products Nutritional Products and Vascular Products. The Established Pharmaceutical Products segment includes the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment includes the sales of a line of adult and pediatric nutritional products. The Nutritional Products includes the sales of diagnostic systems and tests for blood banks hospitals commercial laboratories and alternate-care testing sites. The Vascular Products includes the sales of coronary endovascular structural heart vessel closure and other medical device products.